论文部分内容阅读
采用米托蒽醌联合COP方案(CMOP)治疗难治性非霍奇金淋巴瘤(NHL)21例。结果完全缓解8例(38 1%) ,部分缓解6例(28 6 %) ,无效7例(33 3 %) ,总有效率66 7 %。
Mitoxantrone combined COP regimen (CMOP) was used to treat 21 cases of refractory non-Hodgkin’s lymphoma (NHL). The results were complete remission in 8 cases (38 1%), partial remission in 6 cases (28 6%), invalid in 7 cases (33 3%), and the total effective rate was 66 7%.